Bank of New York Mellon Corp
BankPosition in TAK — Takeda Pharmaceutical Co Ltd
CIK 1390777
NEW YORK, NY
Position in TAK
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,395,283
+$662,394 QoQ
Shares Held
129,335
+16.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 99.95747477480961.ToString("F0")%
Shared 0.ToString("F0")%
None 0.04252522519039703.ToString("F0")%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $1,372,047,844 across 46 Drug Manufacturers - Specialty & Generic names. TAK ranks #27 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,899,720 | $460,985,889 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
329,148 | $195,178,172 | |
| 3 | VTRS |
Viatris Inc
|
14,128,917 | $190,881,662 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
702,492 | $92,546,288 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,809,888 | $91,170,611 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,794,432 | $54,048,287 | |
| 7 | ALKS |
Alkermes plc.
|
1,036,460 | $36,649,221 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
463,751 | $35,175,507 |
All Filings in TAK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,395,283 | 129,335 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,732,889 | 111,154 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,898,352 | 129,669 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $2,176,069 | 140,755 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,925,350 | 129,479 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $1,388,768 | 104,892 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,272,744 | 89,504 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,158,567 | 89,534 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,545,523 | 111,269 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,716,622 | 120,296 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $2,120,825 | 137,093 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $2,214,071 | 140,934 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $2,473,976 | 150,120 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,196,821 | 140,822 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,293,340 | 99,718 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,003,086 | 71,445 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $913,628 | 63,801 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $689,621 | 50,596 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,001,897 | 61,166 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $1,114,951 | 66,248 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,190,386 | 65,191 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $1,531,381 | 85,840 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,970,217 | 109,884 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,991,539 | 131,195 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||